Balla A - Search Results

1

Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype.

Menezes EC, Shah R, Laughlin L, Vinod KY, Smiley JF, Cunha C, Balla A, Sershen H, Castellanos FX, Corvelo A, Teixeira CM. Menezes EC, et al. Among authors: balla a. J Neurosci. 2021 Mar 24;41(12):2723-2732. doi: 10.1523/JNEUROSCI.2608-20.2021. Epub 2021 Feb 3. J Neurosci. 2021. PMID: 33536200 Free PMC article.

2

Functional connectivity fMRI in mouse brain at 7T using isoflurane.

Guilfoyle DN, Gerum SV, Sanchez JL, Balla A, Sershen H, Javitt DC, Hoptman MJ. Guilfoyle DN, et al. Among authors: balla a. J Neurosci Methods. 2013 Apr 15;214(2):144-8. doi: 10.1016/j.jneumeth.2013.01.019. Epub 2013 Jan 31. J Neurosci Methods. 2013. PMID: 23376497 Free PMC article.

3

Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling.

Balla A, Dong B, Shilpa BM, Vemuri K, Makriyannis A, Pandey SC, Sershen H, Suckow RF, Vinod KY. Balla A, et al. Neuropharmacology. 2018 Mar 15;131:200-208. doi: 10.1016/j.neuropharm.2017.10.040. Epub 2017 Nov 3. Neuropharmacology. 2018. PMID: 29109060 Free PMC article.

4

Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia.

Balla A, Schneider S, Sershen H, Javitt DC. Balla A, et al. Eur Neuropsychopharmacol. 2012 Dec;22(12):902-10. doi: 10.1016/j.euroneuro.2012.03.006. Epub 2012 May 5. Eur Neuropsychopharmacol. 2012. PMID: 22561005 Free PMC article.

5

Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus.

Sershen H, Balla A, Lajtha A, Vizi ES. Sershen H, et al. Among authors: balla a. Neuroscience. 1997 Mar;77(1):121-30. doi: 10.1016/s0306-4522(96)00425-3. Neuroscience. 1997. PMID: 9044380

6

Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.

Balla A, Sershen H, Serra M, Koneru R, Javitt DC. Balla A, et al. Neuropsychopharmacology. 2003 Jan;28(1):34-44. doi: 10.1038/sj.npp.1300019. Neuropsychopharmacology. 2003. PMID: 12496938

7

Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists.

Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H. Javitt DC, et al. Among authors: balla a. Neuropsychopharmacology. 2004 Feb;29(2):300-7. doi: 10.1038/sj.npp.1300313. Neuropsychopharmacology. 2004. PMID: 14560321

8

Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.

Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC. Sershen H, et al. Among authors: balla a. Neurochem Int. 2008 Jan;52(1-2):119-29. doi: 10.1016/j.neuint.2007.07.011. Epub 2007 Jul 20. Neurochem Int. 2008. PMID: 17716783

9

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.

Javitt DC, Balla A, Sershen H, Lajtha A. Javitt DC, et al. Among authors: balla a. Biol Psychiatry. 1999 Mar 15;45(6):668-79. doi: 10.1016/s0006-3223(98)00237-6. Biol Psychiatry. 1999. PMID: 10187996

10

Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release.

Balla A, Koneru R, Smiley J, Sershen H, Javitt DC. Balla A, et al. Neuropsychopharmacology. 2001 Aug;25(2):157-64. doi: 10.1016/S0893-133X(01)00230-5. Neuropsychopharmacology. 2001. PMID: 11425499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page